Assertio Holdings (ASRT) Interest & Investment Income (2023 - 2026)
Assertio Holdings' (ASRT) quarterly Interest & Investment Income came in at $469000.0 in Q1 2026, down 34.86% year-on-year from $720000.0 in Q1 2025, and down 22.61% quarter-over-quarter from $606000.0 in Q4 2025.
Assertio Holdings (ASRT) Interest & Investment Income (2023 - 2026) Analysis & Trends
Assertio Holdings has disclosed Interest & Investment Income across 4 years of filings, most recently posting $469000.0 for Q1 2026.
- Interest & Investment Income for Q1 2026 came in at $469000.0, down 34.86% year-over-year; the trailing twelve-month figure through Mar 2026 was $2.4 million (down 25.24% YoY), and the FY2025 annual result was $2.7 million, down 17.26% from the prior year.
- Interest & Investment Income came in at $469000.0 for Q1 2026 at Assertio Holdings, down from $606000.0 in the prior quarter.
- In the past five years, Interest & Investment Income ranged from a high of $887000.0 in Q3 2024 to a low of $469000.0 in Q1 2026.
- The 4-year median for Interest & Investment Income is $682500.0 (2023), against an average of $691583.3.
- Across the five-year window, Interest & Investment Income surged 46.61% in 2024 and slumped 34.86% in 2026, its largest moves.
- Assertio Holdings' Interest & Investment Income stood at $690000.0 in 2023, then advanced by 13.04% to $780000.0 in 2024, then declined by 22.31% to $606000.0 in 2025, then dropped by 22.61% to $469000.0 in 2026.
- The last three Interest & Investment Income figures came in at $469000.0 (Q1 2026), $606000.0 (Q4 2025), and $664000.0 (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Int & Inv Inc (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 38.77 Bn | 35.04 Bn | 1.97 Bn | - |
| 2 | Zoetis | 34.11 Bn | 32.16 Bn | 1.62 Bn | - |
| 3 | United Therapeutics | 23.68 Bn | 21.53 Bn | 648.10 Mn | 41.80 Mn |
| 4 | Aurora Cannabis | 16.48 Bn | 16.40 Bn | 33.43 Mn | 3.45 Mn |
| 5 | Neurocrine Biosciences | 16.19 Bn | 14.88 Bn | 800.70 Mn | 28.10 Mn |
| 6 | Elanco Animal Health | 11.44 Bn | 11.01 Bn | 785.00 Mn | - |
| 7 | Alkermes | 7.28 Bn | 6.77 Bn | -116.06 Mn | 8.54 Mn |
| 8 | Lantheus Holdings | 6.48 Bn | 5.98 Bn | 230.92 Mn | 4.97 Mn |
| 9 | Hims & Hers Health | 6.35 Bn | 5.60 Bn | 396.79 Mn | - |
| 10 | Assertio Holdings | 151.07 Mn | 79.50 Mn | 7.22 Mn | 469,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 469,000.00 |
| Dec 31, 2025 | 606,000.00 |
| Sep 30, 2025 | 664,000.00 |
| Jun 30, 2025 | 675,000.00 |
| Mar 31, 2025 | 720,000.00 |
| Dec 31, 2024 | 780,000.00 |
| Sep 30, 2024 | 887,000.00 |
| Jun 30, 2024 | 842,000.00 |
| Mar 31, 2024 | 711,000.00 |
| Dec 31, 2023 | 690,000.00 |
| Sep 30, 2023 | 605,000.00 |
| Jun 30, 2023 | 650,000.00 |